Entry Detail


General Information

Database ID:TRD03031
Confidence:Low
Contents:>> tsRNA Information
>> tsRNA Association Statistics
>> Disease Information
>> Disease Association Statistics
>> Evidence Support
>> Reference



tsRNA Information

tsRNA Name:5a_tRF-Asp-GTC
tsRNA Type:tRF-5
Amino acid and Anticodon:AspGTC
Sequence:TCCTCGTTAGTATAGTGG
Related Target:N/A
Predicted Target:ZNF546//GLRA3//VWC2//ACSM1//ABLIM2//USP3//SATL1//HABP4//OR12D3//PREX1
External Links:
MINTbase ID:tRF-18-897PVP04
tRFdb ID:tRFdb-5032a

[1] gtRNAdb_ID:tRNA-Asp-GTC-3-1
Anticodon:AspGTC
tRNA_number:trna144
Chromosome:6
Strand:-
Coordinate:Start Site(bp): 27551290        End Site(bp): 27551307

[2] gtRNAdb_ID:tRNA-Asp-GTC-2-5
Anticodon:AspGTC
tRNA_number:trna69
Chromosome:1
Strand:-
Coordinate:Start Site(bp): 161440259        End Site(bp): 161440276

[3] gtRNAdb_ID:tRNA-Asp-GTC-2-4
Anticodon:AspGTC
tRNA_number:trna72
Chromosome:1
Strand:-
Coordinate:Start Site(bp): 161432878        End Site(bp): 161432895

[4] gtRNAdb_ID:tRNA-Asp-GTC-2-3
Anticodon:AspGTC
tRNA_number:trna75
Chromosome:1
Strand:-
Coordinate:Start Site(bp): 161425468        End Site(bp): 161425485

[5] gtRNAdb_ID:tRNA-Asp-GTC-2-2
Anticodon:AspGTC
tRNA_number:trna78
Chromosome:1
Strand:-
Coordinate:Start Site(bp): 161418087        End Site(bp): 161418104

[6] gtRNAdb_ID:tRNA-Asp-GTC-2-1
Anticodon:AspGTC
tRNA_number:trna81
Chromosome:1
Strand:-
Coordinate:Start Site(bp): 161410669        End Site(bp): 161410686

[7] gtRNAdb_ID:tRNA-Asp-GTC-2-10
Anticodon:AspGTC
tRNA_number:trna10
Chromosome:12
Strand:-
Coordinate:Start Site(bp): 125424247        End Site(bp): 125424264

[8] gtRNAdb_ID:tRNA-Asp-GTC-2-9
Anticodon:AspGTC
tRNA_number:trna12
Chromosome:12
Strand:-
Coordinate:Start Site(bp): 125411945        End Site(bp): 125411962

[9] gtRNAdb_ID:tRNA-Asp-GTC-2-8
Anticodon:AspGTC
tRNA_number:trna4
Chromosome:12
Strand:+
Coordinate:Start Site(bp): 96429799        End Site(bp): 96429816

[10] gtRNAdb_ID:tRNA-Asp-GTC-2-11
Anticodon:AspGTC
tRNA_number:trna38
Chromosome:17
Strand:-
Coordinate:Start Site(bp): 8125610        End Site(bp): 8125627

[11] gtRNAdb_ID:tRNA-Asp-GTC-2-6
Anticodon:AspGTC
tRNA_number:trna45
Chromosome:6
Strand:+
Coordinate:Start Site(bp): 27447453        End Site(bp): 27447470

[12] gtRNAdb_ID:tRNA-Asp-GTC-2-7
Anticodon:AspGTC
tRNA_number:trna48
Chromosome:6
Strand:+
Coordinate:Start Site(bp): 27471523        End Site(bp): 27471540

[13] gtRNAdb_ID:tRNA-Asp-GTC-1-1
Anticodon:AspGTC
tRNA_number:trna5
Chromosome:12
Strand:+
Coordinate:Start Site(bp): 98897281        End Site(bp): 98897298



tsRNA Association Statistics

Total Associated Disease Number:1
More Information
Network:
(Display the first 15 nodes)



Disease Information

 MeSHDisease Ontology
Disease ID:D002289DOID:3908
Disease Name:Carcinoma, Non-Small-Cell Lunglung non-small cell carcinoma
Category:MeSHDisease Ontology
Type:Neoplasms//Respiratory Tract Diseasesdisease of anatomical entity//disease of cellular proliferation
Define:A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy.A lung carcinoma that is characterized as any type of epithelial lung cancer other than small cell lung carcinoma.
Alias:Carcinoma, Non-Small Cell Lung//Non-Small Cell Lung Cancer//Non-Small Cell Lung Carcinoma//Non-Small-Cell Lung Carcinoma//Nonsmall Cell Lung CancerNon-small cell lung cancer//non-small cell lung carcinoma//NSCLC



Disease Association Statistics

Total Associated tsRNA Number:132
More Information
Network:
(Display the first 15 nodes)



Evidence Support

Strong Evidence:N/A
Weak Evidence:Data Mining



Reference

[1] PubMed ID:35892120
Disease Name:Carcinoma, Non-Small-Cell Lung
Tissue:Lung
Dysfunction Pattern:Up-Regulation
Validated Method:Data Mining
Description:Due to the different data platforms, GEO and TCGA were separately calculated. We used Deseq2 and t test in two GEO datasets (GEO: GSE83527 and GEO: GSE62812) and TCGA-LUAD cohort based on both raw read counts and normalized expression profile transcripts per million mapped reads (TPM), respectively.
Comparision:Cancer VS Normal
Mechanism:N/A